Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

2 hours ago 3

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read Entire Article

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Related

Australia news live: Anthony Albanese says OpenAI agent hack...

VC firm Bessemer now has another $5.75B to invest in (what e...

Essex cricketer Das charged with counts of rape

Trending

Popular

foreignaffairs - Europe Needs a New Way to Cooperate

pewresearch - Methodology

ft - Mission impossible? Abel faces tricky task leading Berkshire...

csmonitor - Hiring is up, GDP is down: Economy sends mixed signals as ta...

newsnationnow - PBS CEO: New children's programming will 'skid to a halt' un...